Antiretroviral therapy-naïve
Showing 26 - 50 of >10,000
HIV, Antiretroviral Therapy Trial in New York (Heart to Heart)
Completed
- HIV
- Antiretroviral Therapy
- Heart to Heart
-
New York, New YorkNew York University College of Nursing
Oct 31, 2022
HIV Trial in Cincinnati (Truvada (tenofovir/emtricitabine), Kaletra (lopinavir/ritonavir))
Completed
- HIV Infections
- Truvada (tenofovir/emtricitabine)
- Kaletra (lopinavir/ritonavir)
-
Cincinnati, OhioUniversity of Cincinnati AIDS Clinical Trials Unit
Jul 14, 2022
Human Immunodeficiency Virus, Treatment, Antiretroviral Therapy Trial in Seattle (TLC-ART)
Recruiting
- Human Immunodeficiency Virus
- +2 more
-
Seattle, WashingtonUW Positve Research, Harborview Medical Center
May 8, 2023
Infection, Human Immunodeficiency Virus, HIV Trial in Worldwide (Dolutegravir/abacavir/lamivudine FDC, Atazanavir, Ritonavir)
Active, not recruiting
- Infection, Human Immunodeficiency Virus
- HIV Infections
- Dolutegravir/abacavir/lamivudine FDC
- +3 more
-
Phoenix, Arizona
- +88 more
Feb 8, 2022
HIV-1-infection Trial in Chapel Hill (MGD014)
Completed
- HIV-1-infection
- MGD014
-
Chapel Hill, North CarolinaUniversity of North Carolina Chapel Hill
Aug 31, 2022
Hiv Trial in Nice (plasma inflammatory markers, CD4/CD8 ratio)
Not yet recruiting
- Hiv
- plasma inflammatory markers
- CD4/CD8 ratio
-
Nice, FranceCHU Nice
Jan 16, 2023
Chronic HIV Infection Trial in Kisumu (POC VL and targeted DRM testing., SOC VL testing)
Completed
- Chronic HIV Infection
- POC VL and targeted DRM testing.
- SOC VL testing
-
Kisumu, KenyaRtcp-Faces
Dec 5, 2022
HIV, Hiv Trial (Community Antiretroviral Therapy)
Not yet recruiting
- HIV Infections
- Hiv
- Community Antiretroviral Therapy
- (no location specified)
Nov 6, 2023
GALIG Gene Products in HIV-1 Infected Under Antiretroviral
Recruiting
- Autophagy
- +3 more
- expression of a panel
-
Orléans, FranceCHR d'Orleans
Nov 17, 2021
HIV-1-infection Trial in Shanghai, Kunming, Hangzhou (B/F/TAF, TDF-based triple ART regimen switching to B/F/TAF)
Recruiting
- HIV-1-infection
- B/F/TAF
- TDF-based triple ART regimen switching to B/F/TAF
-
Shanghai, Shanghai, China
- +2 more
Dec 1, 2022
HIV, Cannabis Use Trial in San Diego (THC Cannabis, CBD Cannabis, Placebo)
Recruiting
- HIV
- Cannabis Use
- THC Cannabis
- +2 more
-
San Diego, CaliforniaUcsd Hnrp-Cmcr
Aug 23, 2022
HIV Infection, Adherence, Medication, Adherence, Treatment Trial in Boston (Next-generation Reader and ID-Cap System, Truvada
Recruiting
- HIV Infection
- +4 more
- Next-generation Reader and ID-Cap System
- +2 more
-
Boston, MassachusettsFenway Health
Dec 20, 2022
HIV-1-infection, Antenatal Care Trial in Lilongwe (iNSC and Adherence supporter training)
Completed
- HIV-1-infection
- Antenatal Care
- iNSC and Adherence supporter training
-
Lilongwe, MalawiBwaila District Hospital
Jan 9, 2023
Extensive Stage Small Cell Lung Cancer Trial in Hangzhou (Tislelizumab, Anlotinib)
Recruiting
- Extensive Stage Small Cell Lung Cancer
-
Hangzhou, Zhejiang, ChinaZhejiang Cancer Hospital
Jun 6, 2023
Open-angle Glaucoma Trial in Yerevan (iStent inject, Travoprost)
Completed
- Open-angle Glaucoma
- iStent inject
- Travoprost
-
Yerevan, ArmeniaS.V. Malayan Ophthalmological Center
Sep 2, 2022
Prostatic Tumors Trial in San Francisco (Pembrolizumab, SD-101, Leuprolide acetate)
Active, not recruiting
- Prostatic Neoplasms
- Pembrolizumab
- +5 more
-
San Francisco, CaliforniaUniversity of California San Francisco
Sep 20, 2022
Multi-Drug Resistant Hiv-1 Infection, HIV-1 Infection Trial run by the National Institute of Allergy and Infectious Diseases
Not yet recruiting
- Multi-Drug Resistant Hiv-1 Infection
- HIV-1 Infection
- UB-421
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
AIDS, AIDS Vaccines Trial in Gent (Blood sample collection)
Completed
- AIDS
- AIDS Vaccines
- Blood sample collection
-
Gent, BelgiumGSK Investigational Site
Apr 14, 2020
Prostatic Adenocarcinoma Trial in Seoul (Enzalutamide)
Not yet recruiting
- Prostatic Adenocarcinoma
-
Seoul, Korea, Korea, Republic ofSamsung Medical Center
Aug 23, 2023
HIV-infected Patients Switching to Long Acting Dual Therapy
Not yet recruiting
- HIV-1-infection
- (no location specified)
Jun 24, 2022
Helicobacter Pylori Infection Trial in New York (Amoxicillin, Omeprazole, Clarithromycin)
Completed
- Helicobacter Pylori Infection
- Amoxicillin
- +2 more
-
New York, New YorkMount Sinai Union Square Division of Digestive Diseases
Jan 6, 2023